TAGLIALATELA, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 11.296
EU - Europa 7.887
AS - Asia 2.244
SA - Sud America 561
AF - Africa 254
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 22.277
Nazione #
US - Stati Uniti d'America 11.157
RU - Federazione Russa 3.085
IE - Irlanda 1.735
SG - Singapore 969
CN - Cina 577
UA - Ucraina 535
BR - Brasile 464
SE - Svezia 425
FI - Finlandia 388
DE - Germania 372
IT - Italia 364
GB - Regno Unito 317
AT - Austria 226
CI - Costa d'Avorio 201
BE - Belgio 175
HK - Hong Kong 149
VN - Vietnam 122
IN - India 110
CA - Canada 81
JP - Giappone 54
FR - Francia 52
PL - Polonia 46
NL - Olanda 43
BD - Bangladesh 38
MX - Messico 37
ES - Italia 36
TR - Turchia 35
AR - Argentina 32
IR - Iran 26
ID - Indonesia 25
ZA - Sudafrica 25
IQ - Iraq 19
LT - Lituania 18
AU - Australia 14
IL - Israele 13
KR - Corea 13
CL - Cile 12
PE - Perù 12
PK - Pakistan 11
RO - Romania 10
VE - Venezuela 10
CO - Colombia 9
CZ - Repubblica Ceca 9
EU - Europa 9
JO - Giordania 9
MY - Malesia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
JM - Giamaica 8
PY - Paraguay 8
SA - Arabia Saudita 8
CH - Svizzera 7
DK - Danimarca 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
PH - Filippine 7
DZ - Algeria 6
TN - Tunisia 6
AL - Albania 5
GR - Grecia 5
HU - Ungheria 5
MA - Marocco 5
MD - Moldavia 5
BY - Bielorussia 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
ET - Etiopia 2
KE - Kenya 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GM - Gambi 1
GT - Guatemala 1
GY - Guiana 1
Totale 22.270
Città #
Dallas 4.061
Dublin 1.732
Jacksonville 1.233
Chandler 1.176
Moscow 995
Singapore 490
Wilmington 420
Beijing 285
Ashburn 274
San Mateo 247
Helsinki 237
Ann Arbor 233
Vienna 217
Houston 216
Abidjan 201
Woodbridge 193
Rome 180
New York 179
Boardman 177
Brussels 174
Princeton 163
The Dalles 150
Los Angeles 135
Hong Kong 133
Falls Church 70
Columbus 69
São Paulo 69
Molise 51
Ho Chi Minh City 44
London 42
Tokyo 42
Council Bluffs 40
Santa Clara 35
Warsaw 33
Redwood City 32
Toronto 31
San Francisco 30
Brooklyn 27
Dearborn 27
Munich 24
Chennai 23
Frankfurt am Main 23
Mountain View 23
Stockholm 23
Montreal 22
Norwalk 22
Poplar 22
Hanoi 21
Jakarta 21
Phoenix 20
Chicago 19
Amsterdam 18
Denver 17
Jinan 17
Nanjing 17
Boston 16
Shenyang 16
Ankara 15
Johannesburg 15
Atlanta 14
Auburn Hills 12
Augusta 12
Da Nang 12
Falkenstein 12
Manchester 12
Naples 12
Seoul 12
Kunming 11
Leawood 11
Mexico City 11
Napoli 11
Seattle 11
Tappahannock 11
Clearwater 10
Curitiba 10
Hefei 10
Mumbai 10
Orem 10
Charlotte 9
Dhaka 9
Haikou 9
Los Altos 9
Zhengzhou 9
Brasília 8
Fortaleza 8
Guangzhou 8
Ottawa 8
Rio de Janeiro 8
Tashkent 8
West Jordan 8
Amman 7
Baghdad 7
Kuala Lumpur 7
Milan 7
Nuremberg 7
Porto Alegre 7
Pune 7
Taiyuan 7
Borås 6
Hangzhou 6
Totale 14.920
Nome #
109. Involvement of the Na+-H+ antiporter on the effect of protein kinase-C activation on dopamine synthesis in rat corpus striatum 2.871
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 254
Consensus group on new-generation antihistamines (CONGA): present status and recommendations 234
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 234
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S-4 region of KCNQ2 causing benign familial neonatal convulsions 205
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 189
BARIUM BLOCKADE OF A CLONAL POTASSIUM CHANNEL AND ITS REGULATION BY A CRITICAL PORE RESIDUE 188
Autism and developmental disability caused by KCNQ3 gain-of-function variants 187
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 183
Adenosine receptors modulate the Na(+)-Ca2+ exchanger in cerebral nerve endings. 180
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 176
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 176
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 175
"Janus face" of nitric oxide action on plasma membrane and intracellular ionic channels 174
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 174
A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance 173
Activation of pre-synaptic M-type K+ channels inhibits [H-3]d-aspartate release by reducing Ca2+ entry through P/Q-type voltage-gated Ca(2+)channels 173
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 172
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 172
A SINGLE NONPOLAR RESIDUE IN THE DEEP PORE OF RELATED K+ CHANNELS ACTS AS A K+-RB+ CONDUCTANCE SWITCH 170
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 168
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 168
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation 166
The occurrence of a Kv7.4 potassium channel in neuronal mitochondria 165
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 164
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 163
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 162
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 160
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. 159
AMPA- and P2X7-receptor-mediated facilitation of [H-3]D-aspartate release from nerve terminals isolated from the rat caudal brainstem 154
Cardiotoxic effects of antihistamines: From basics to clinics (... and back) 154
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 152
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 151
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 149
Cell viability studies and operation in cellular culture medium of n-type organic field-effect transistors 147
Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels 147
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha(1) subunit reduces membrane expression and impairs gating by agonists 145
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs 141
Protective role of Kv7 channels in oxygen and glucose deprivation-induced damage in rat caudate brain slices 140
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 137
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 134
Expression, Localization, and Pharmacological Role of K(v)7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 132
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 131
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 131
C-TERMINUS DETERMINANTS FOR MG2+ AND POLYAMINE BLOCK OF THE INWARD RECTIFIER K+ CHANNEL IRK1 130
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons. 129
CORRELATING THE CLINICAL AND GENETIC FEATURES OF BENIGN FAMILIAL NEONATAL SEIZURES (BFNS) WITH THE FUNCTIONAL CONSEQUENCES OF THE UNDERLYING MUTATIONS 126
Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures 125
Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species 121
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 121
Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A 120
POSSIBLE INHIBITORY ROLE OF HISTAMINE H-2 RECEPTORS IN THE CONTROL OF BASAL TSH SECRETION IN MALE-RATS - STUDIES WITH DIMAPRIT, A SELECTIVE H-2-RECEPTOR AGONIST 119
Driving with no brakes: molecular pathophysiology of kv7 potassium channels 118
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 118
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits 116
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 115
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 114
K(V)7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fund 114
EXCHANGE OF CONDUCTION PATHWAYS BETWEEN 2 RELATED K+ CHANNELS 114
CYTOPLASMIC ALKALINIZATION INDUCED BY INSULIN THROUGH AN ACTIVATION OF NA+-H+ ANTIPORTER INHIBITS TYROSINE-HYDROXYLASE ACTIVITY IN STRIATAL SYNAPTOSOMES 114
herg encodes a K+ current highly conserved in tumors of different histogenesis: A selective advantage for cancer cells? 113
Up-regulation and increased activity of K(V)3.4 channels and their accessory subunit MinK-Related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death 113
The gene encoding a cationic amino acid transporter (SLC7A4) maps to the region deleted in the velocardiofacial syndrome 113
COMPARISON OF H-5, S-6, AND H-5-S-6 EXCHANGES ON PORE PROPERTIES OF VOLTAGE-DEPENDENT K+ CHANNELS 113
GATING CURRENTS OF THE CLONED DELAYED-RECTIFIER K+ CHANNEL DRK1 112
Pre-synaptic BK channels selectively control glutamate versus GABA release from cortical and hippocampal nerve terminals 112
SPERMINE AND SPERMIDINE AS GATING MOLECULES FOR INWARD RECTIFIER K+ CHANNELS 111
H-1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects 111
VOLTAGE-DEPENDENT INHIBITION AND FACILITATION OF CA CHANNEL ACTIVATION BY GTP-GAMMA-S AND CA-AGONISTS IN ADULT-RAT SENSORY NEURONS 110
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 110
Specification of skeletal muscle differentiation by repressor element-1 silencing transcription factor (REST)-regulated Kv7.4 potassium channels 109
SPECIFICATION OF PORE PROPERTIES BY THE CARBOXYL-TERMINUS OF INWARDLY RECTIFYING K+ CHANNELS 109
PLASMA PROLACTIN LEVELS IN THE INFERIOR PETROSAL SINUSES IN VARIOUS PITUITARY DISORDERS DURING PERIHYPOPHYSEAL PHLEBOGRAPHY 108
M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals 108
Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus 108
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 108
Effects of manidipine and nitrendipine enantiomers on the plateau phase of K+-induced intracellular Ca2+ increase in GH(3) cells 107
THE NA+-CA2+ EXCHANGER ACTIVITY IN CEREBROCORTICAL NERVE-ENDINGS IS REDUCED IN OLD COMPARED TO YOUNG AND MATURE RATS WHEN IT OPERATES AS A CA2+ INFLUX OR EFFLUX PATHWAY 107
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 107
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 107
NA+-CA-2+ EXCHANGE ACTIVITY IN CENTRAL NERVE-ENDINGS .1. IONIC CONDITIONS THAT DISCRIMINATE CA-45(2+) UPTAKE THROUGH THE EXCHANGER FROM THAT OCCURRING THROUGH VOLTAGE-OPERATED CA-2+ CHANNELS 106
Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists. 106
Brain distribution of the Na+/Ca2+ exchanger-encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system 106
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 105
Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome 105
DIFFERENCES BETWEEN THE DEEP PORES OF K+ CHANNELS DETERMINED BY AN INTERACTING PAIR OF NONPOLAR AMINO-ACIDS 105
PURE UPTAKE BLOCKERS OF DOPAMINE CAN REDUCE PROLACTIN SECRETION - STUDIES WITH DICLOFENSINE 105
STRUCTURAL MOTIFS UNDERLYING VOLTAGE-DEPENDENT K+ CHANNEL FUNCTION 105
PHARMACOLOGICAL CHARACTERIZATION OF SEROTONIN RECEPTORS INVOLVED IN THE CONTROL OF PROLACTIN SECRETION 104
Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy 104
Cardiotoxic potential and CNS effects of first-generation antihistamines 104
MEMBRANE EVENTS AND IONIC PROCESSES INVOLVED IN DOPAMINE RELEASE FROM TUBEROINFUNDIBULAR NEURONS .2. EFFECT OF THE INHIBITION OF THE NA+-CA++ EXCHANGE BY AMILORIDE 104
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 103
Gating currents from neuronal K(V)7.4 channels General features and correlation with the ionic conductance 102
The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants 102
INTERNAL AND EXTERNAL TEA BLOCK IN SINGLE CLONED K+ CHANNELS 101
GATING OF INWARDLY RECTIFYING K+ CHANNELS LOCALIZED TO A SINGLE NEGATIVELY CHARGED RESIDUE 101
RESCUE OF LETHAL SUBUNITS INTO FUNCTIONAL K+ CHANNELS 101
EVIDENCE FOR A DIFFERENTIAL INTERACTION OF BUPRENORPHINE WITH OPIATE RECEPTOR SUBTYPES CONTROLLING PROLACTIN SECRETION 101
CLONED HUMAN INWARD RECTIFIER K+ CHANNEL AS A TARGET FOR CLASS-III METHANESULFONANILIDES 100
Totale 16.260
Categoria #
all - tutte 98.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.218


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021834 0 0 0 0 0 139 187 13 186 14 232 63
2021/20221.112 57 228 8 56 107 93 27 95 200 100 55 86
2022/20234.704 531 171 111 396 371 485 21 221 2.116 126 78 77
2023/2024786 173 85 47 15 17 150 27 100 14 51 14 93
2024/20252.553 242 93 237 106 452 121 99 217 191 71 324 400
2025/20268.919 429 1.519 2.971 539 2.706 755 0 0 0 0 0 0
Totale 22.508